Your browser doesn't support javascript.
loading
Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies.
Chen, Si; Zhang, Zhengyuan; Wang, Qian; Yang, Qi; Yin, Li; Ning, Lishan; Chen, Zhilong; Tang, Jielin; Deng, Weiqi; He, Ping; Li, Hengchun; Shi, Linjing; Deng, Yijun; Liu, Zijian; Bu, Hemeng; Zhu, Yaohui; Liu, Wenming; Qu, Linbing; Feng, Liqiang; Xiong, Xiaoli; Sun, Baoqing; Zhong, Nanshan; Li, Feng; Li, Pingchao; Chen, Xinwen; Chen, Ling.
Afiliação
  • Chen S; Guangzhou Institute of Infectious Disease, Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Zhang Z; Guangzhou National Laboratory, Guangzhou, China.
  • Wang Q; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Yang Q; University of Chinese Academy of Sciences, Beijing, China.
  • Yin L; Guangzhou National Laboratory, Guangzhou, China.
  • Ning L; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
  • Chen Z; Guangzhou National Laboratory, Guangzhou, China.
  • Tang J; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Deng W; University of Chinese Academy of Sciences, Beijing, China.
  • He P; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Li H; University of Chinese Academy of Sciences, Beijing, China.
  • Shi L; Xiamen United Institute of Respiratory Health, Xiamen, China.
  • Deng Y; Guangzhou National Laboratory, Guangzhou, China.
  • Liu Z; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Bu H; University of Chinese Academy of Sciences, Beijing, China.
  • Zhu Y; Guangzhou National Laboratory, Guangzhou, China.
  • Liu W; Guangzhou National Laboratory, Guangzhou, China.
  • Qu L; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Feng L; University of Chinese Academy of Sciences, Beijing, China.
  • Xiong X; Guangzhou National Laboratory, Guangzhou, China.
  • Sun B; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Zhong N; University of Chinese Academy of Sciences, Beijing, China.
  • Li F; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Li P; University of Chinese Academy of Sciences, Beijing, China.
  • Chen X; State Key Laboratory of Respiratory Disease, Center for Cell Lineage Research, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China.
  • Chen L; University of Chinese Academy of Sciences, Beijing, China.
Signal Transduct Target Ther ; 9(1): 190, 2024 Jul 22.
Article em En | MEDLINE | ID: mdl-39039046
ABSTRACT
The upper respiratory tract is the initial site of SARS-CoV-2 infection. Nasal spike-specific secretory immunoglobulin A (sIgA) correlates with protection against Omicron breakthrough infection. We report that intranasal vaccination using human adenovirus serotype 5 (Ad5) vectored Omicron spike in people who previously vaccinated with ancestral vaccine could induce robust neutralizing sIgA in the nasal passage. Nasal sIgA was predominantly present in dimeric and multimeric forms and accounted for nearly 40% of total proteins in nasal mucosal lining fluids (NMLFs). A low-level IgG could also be detected in NMLFs but not IgM, IgD, and IgE. After a complete nasal wash, sIgA in the nasal passage could be replenished rapidly within a few hours. A comparison of purified paired serum IgA, serum IgG, and nasal sIgA from the same individuals showed that sIgA was up to 3-logs more potent than serum antibodies in binding to spikes and in neutralizing Omicron subvariants. Serum IgG and IgA failed to neutralize XBB and BA.2.86, while nasal sIgA retained potent neutralization against these newly emerged variants. Further analysis showed that sIgA was more effective than IgG or IgA in blocking spike-mediated cell-to-cell transmission and protecting hACE2 mice from XBB challenge. Using a sIgA monoclonal antibody as a reference, we estimated that the total nasal sIgA contains about 2.6-3.9% spike-specific sIgA in NMLFs collected approximately one month after intranasal vaccination. Our study provided insights for developing intranasal vaccines that can induce sIgA to build an effective and mutation-resistant first-line immune barrier against constantly emerging variants.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Administração Intranasal / Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Administração Intranasal / Anticorpos Neutralizantes / Glicoproteína da Espícula de Coronavírus / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido